Walid Abi-Saab
Chief Tech/Sci/R&D Officer chez UNIQURE N.V.
Fortune : 606 840 $ au 31/03/2024
Profil
Le Dr Walid Abi-Saab, MD, est médecin en chef chez Galapagos NV. Le Dr. Abi-Saab était auparavant employé en tant que Group Vice President-Clinical Development par Shire Plc et professeur adjoint en psychiatrie et neurochirurgie à la Yale School of Medicine. Il a obtenu son doctorat à l'Université de Saint Joseph (Macao).
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
UNIQURE N.V.
0,24% | 01/03/2024 | 116 700 ( 0,24% ) | 606 840 $ | 31/03/2024 |
Postes actifs de Walid Abi-Saab
| Sociétés | Poste | Début |
|---|---|---|
| UNIQURE N.V. | Chief Tech/Sci/R&D Officer | 26/06/2023 |
Anciens postes connus de Walid Abi-Saab
| Sociétés | Poste | Fin |
|---|---|---|
| GALAPAGOS NV | Chief Tech/Sci/R&D Officer | 31/12/2022 |
Shire International GmbH (Switzerland)
 Shire International GmbH (Switzerland) Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire International GmbH is a pharmaceutical company based in Zug, Switzerland. The Swiss company develops, manufactures, and markets pharmaceuticals. | Corporate Officer/Principal | - |
| SHIRE | Corporate Officer/Principal | - |
| Yale School of Medicine | Corporate Officer/Principal | - |
Formation de Walid Abi-Saab
| American University of Beirut | Undergraduate Degree |
| Université Saint-Joseph | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GALAPAGOS NV | Health Technology |
| UNIQURE N.V. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Shire International GmbH (Switzerland)
Shire International GmbH (Switzerland) Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire International GmbH is a pharmaceutical company based in Zug, Switzerland. The Swiss company develops, manufactures, and markets pharmaceuticals. | Health Technology |
